Unknown PHASE1 INTERVENTIONAL NCT00129350

Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation

An Assessment of Patient Outcomes Following a Rehabilitation Programme for Patients Who Have Received Lung or Heart-Lung Transplant - a Randomised Controlled Trial

Sponsor: Royal Brompton & Harefield NHS Foundation Trust

Conditions Alveolitis, Fibrosing Bronchiectasis Cystic Fibrosis Emphysema Lung Diseases

Interventions Pulmonary rehabilitation programme

Updated 5 times since 2017 Last updated: Sep 6, 2005 Started: Sep 30, 2004 Completion: Feb 29, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00129350, this PHASE1 trial focuses on Alveolitis, Fibrosing and Bronchiectasis and remains ongoing. Sponsored by Royal Brompton & Harefield NHS Foundation Trust, it has been updated 5 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Sep 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Royal Brompton & Harefield NHS Foundation Trust

Data source: Royal Brompton & Harefield NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Harefield, United Kingdom